Cargando…

Robust antiviral activity of commonly prescribed antidepressants against emerging coronaviruses: in vitro and in silico drug repurposing studies

During the current coronavirus disease 2019 (COVID-19) pandemic, symptoms of depression are commonly documented among both symptomatic and asymptomatic quarantined COVID-19 patients. Despite that many of the FDA-approved drugs have been showed anti-SARS-CoV-2 activity in vitro and remarkable efficac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kutkat, Omnia, Moatasim, Yassmin, Al‐Karmalawy, Ahmed A., Abulkhair, Hamada S., Gomaa, Mokhtar R., El-Taweel, Ahmed N., Abo Shama, Noura M., GabAllah, Mohamed, Mahmoud, Dina B., Kayali, Ghazi, Ali, Mohamed A., Kandeil, Ahmed, Mostafa, Ahmed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331004/ https://www.ncbi.nlm.nih.gov/pubmed/35902647 http://dx.doi.org/10.1038/s41598-022-17082-6

Ejemplares similares

Incidence, household transmission, and neutralizing antibody seroprevalence of Coronavirus Disease 2019 in Egypt: Results of a community-based cohort
por: Gomaa, Mokhtar R., et al.
Publicado: (2021)

Potent Antiviral Activity of Vitamin B12 against Severe Acute Respiratory Syndrome Coronavirus 2, Middle East Respiratory Syndrome Coronavirus, and Human Coronavirus 229E
por: Moatasim, Yassmin, et al.
Publicado: (2023)

EGYVIR: An immunomodulatory herbal extract with potent antiviral activity against SARS-CoV-2
por: Roshdy, Wael H., et al.
Publicado: (2020)

Common childhood vaccines do not elicit a cross-reactive antibody response against SARS-CoV-2
por: Kandeil, Ahmed, et al.
Publicado: (2020)

FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2
por: Mostafa, Ahmed, et al.
Publicado: (2020)

Bioactive Polyphenolic Compounds Showing Strong Antiviral Activities against Severe Acute Respiratory Syndrome Coronavirus 2
por: Kandeil, Ahmed, et al.
Publicado: (2021)

Determinants of having severe acute respiratory syndrome coronavirus 2 neutralizing antibodies in Egypt
por: El Rifay, Amira S., et al.
Publicado: (2021)

Impact of Individual Viral Gene Segments from Influenza A/H5N8 Virus on the Protective Efficacy of Inactivated Subtype-Specific Influenza Vaccine
por: Moatasim, Yassmin, et al.
Publicado: (2021)

Investigating the Potential Anti-SARS-CoV-2 and Anti-MERS-CoV Activities of Yellow Necklacepod among Three Selected Medicinal Plants: Extraction, Isolation, Identification, In Vitro, Modes of Action, and Molecular Docking Studies
por: Abd-Alla, Howaida I., et al.
Publicado: (2022)

Comparative pathogenic potential of avian influenza H7N3 viruses isolated from wild birds in Egypt and their sensitivity to commercial antiviral drugs
por: Kayed, Ahmed E., et al.
Publicado: (2023)

Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine: Preclinical Studies
por: Kandeil, Ahmed, et al.
Publicado: (2021)

Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Antibodies in Egyptian Convalescent Plasma Donors
por: Gomaa, Mokhtar R., et al.
Publicado: (2020)

Active surveillance and genetic evolution of avian influenza viruses in Egypt, 2016–2018
por: Kandeil, Ahmed, et al.
Publicado: (2019)

Insights into Genetic Characteristics and Virological Features of Endemic Avian Influenza A (H9N2) Viruses in Egypt from 2017–2021
por: El Sayes, Mohamed, et al.
Publicado: (2022)

Systematic, active surveillance for Middle East respiratory syndrome coronavirus in camels in Egypt
por: Ali, Mohamed A, et al.
Publicado: (2017)

We are underestimating, again, the true burden of H5N1 in humans
por: Gomaa, Mokhtar, et al.
Publicado: (2023)

In Vitro and In Vivo Antiviral Studies of New Heteroannulated 1,2,3-Triazole Glycosides Targeting the Neuraminidase of Influenza A Viruses
por: Kutkat, Omnia, et al.
Publicado: (2022)

Comparative Virological and Pathogenic Characteristics of Avian Influenza H5N8 Viruses Detected in Wild Birds and Domestic Poultry in Egypt during the Winter of 2016/2017
por: Moatasim, Yassmin, et al.
Publicado: (2019)

Delineating a potent antiviral activity of Cuphea ignea extract loaded nano-formulation against SARS-CoV-2: In silico and in vitro studies
por: Mahmoud, Dina B., et al.
Publicado: (2021)

Coding-Complete Genome Sequences of Two SARS-CoV-2 Isolates from Egypt
por: Kandeil, Ahmed, et al.
Publicado: (2020)

Highly Pathogenic Avian Influenza A(H5N1) Virus Clade 2.3.4.4b in Wild Birds and Live Bird Markets, Egypt
por: El-Shesheny, Rabeh, et al.
Publicado: (2022)

Naturally Available Flavonoid Aglycones as Potential Antiviral Drug Candidates against SARS-CoV-2
por: Al-Karmalawy, Ahmed A., et al.
Publicado: (2021)

Incidence and seroprevalence of seasonal influenza a viruses in Egypt: Results of a community‐based cohort study
por: Gomaa, Mokhtar R., et al.
Publicado: (2022)

Middle East respiratory syndrome coronavirus infection in non-camelid domestic mammals
por: Kandeil, Ahmed, et al.
Publicado: (2019)

Quercitrin loaded cyclodextrin based nanosponge as a promising approach for management of lung cancer and COVID-19
por: Abou Taleb, Sally, et al.
Publicado: (2022)

Corrigendum to “Quercitrin loaded cyclodextrin based nanosponge as a promising approach for management of lung cancer and COVID-19” [J. Drug Deliv. Sci. Technol. 77 (2022) 103921]
por: Taleb, Sally Abou, et al.
Publicado: (2023)

Scrutinizing the Feasibility of Nonionic Surfactants to Form Isotropic Bicelles of Curcumin: a Potential Antiviral Candidate Against COVID-19
por: Mahmoud, Dina B., et al.
Publicado: (2021)

Genetic and Antigenic Characteristics of Highly Pathogenic Avian Influenza A(H5N8) Viruses Circulating in Domestic Poultry in Egypt, 2017–2021
por: Kandeil, Ahmed, et al.
Publicado: (2022)

Active Surveillance for Avian Influenza Virus, Egypt, 2010–2012
por: Kayali, Ghazi, et al.
Publicado: (2014)

Induced humoral immunity of different types of vaccines against most common variants of SARS-CoV-2 in Egypt prior to Omicron outbreak
por: El-Shesheny, Rabeh, et al.
Publicado: (2022)

Sinapic Acid Suppresses SARS CoV-2 Replication by Targeting Its Envelope Protein
por: Orfali, Raha, et al.
Publicado: (2021)

Diversity of Astroviruses Circulating in Humans, Bats, and Wild Birds in Egypt
por: El Taweel, Ahmed, et al.
Publicado: (2020)

3-Alkenyl-2-oxindoles: Synthesis, antiproliferative and antiviral properties against SARS-CoV-2
por: Girgis, Adel S., et al.
Publicado: (2021)

Complete Genome Sequence of Middle East Respiratory Syndrome Coronavirus Isolated from a Dromedary Camel in Egypt
por: Kandeil, Ahmed, et al.
Publicado: (2016)

Discovery of novel thioquinazoline-N-aryl-acetamide/N-arylacetohydrazide hybrids as anti-SARS-CoV-2 agents: Synthesis, in vitro biological evaluation, and molecular docking studies
por: Abdel-Mohsen, Heba T., et al.
Publicado: (2023)

Telaprevir is a potential drug for repurposing against SARS-CoV-2: computational and in vitro studies
por: Mahmoud, Amal, et al.
Publicado: (2021)

β-Blockers bearing hydroxyethylamine and hydroxyethylene as potential SARS-CoV-2 Mpro inhibitors: rational based design, in silico, in vitro, and SAR studies for lead optimization
por: Hamed, Mohammed I. A., et al.
Publicado: (2021)

A Recombinant Influenza A/H1N1 Carrying A Short Immunogenic Peptide of MERS-CoV as Bivalent Vaccine in BALB/c Mice
por: Shehata, Mahmoud M., et al.
Publicado: (2019)

Incidence and Seroprevalence of Avian Influenza in a Cohort of Backyard Poultry Growers, Egypt, August 2015–March 2019
por: Gomaa, Mokhtar R., et al.
Publicado: (2020)

Aurasperone A Inhibits SARS CoV-2 In Vitro: An Integrated In Vitro and In Silico Study
por: ElNaggar, Mai H., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_osdfq6gj7lhn6bhoo17oddi1kc